John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Clinical trial policy ...

Palmer is investigating how telehealth is driving the consumerization of drugs. This is Part 6 of the series The VirtualRx Boom. Katie covers the impact of health technology on patients, clinicians, ...

AstraZeneca agreed to pay $34 million to settle claims that the company paid kickbacks to improperly influence prescriptions ...

What is urgently needed is a shift from pathogen-specific diagnostics toward pathogen-agnostic diagnostic systems,” write ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Isabella is a chronic disease reporter writing about how the Trump administration is tackling the nation’s health epidemic — or not. You can reach her on Signal at isabellacueto.03. WASHINGTON — A ...

A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.

The presidential fitness test, a divisive hallmark of children’s education from the 1960s to the 2010s, is back as part of ...

Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...